ALBT Avalon GloboCare
- 0.420
- +0.003+0.72%
- 0.411
- -0.009-2.21%
Avalon GloboCare News
Manhattan Apartment Rents Drop Even as Leasing Activity Picks Up
Manhattan apartment rents unexpectedly slipped in May, a “sideways” move for the market at the start of one of its typically busiest seasons.
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Core & Main Inc (NYSE:CNM) fell sharply during Tuesday's session after the company reported mixed first-quarter financial results.Core & Main posted quarterly earnings of 49 cents per share,
US Stocks Lower; Donaldson Earnings Beat Views
U.S. stocks traded lower this morning, with the Dow Jones falling more than 70 points on Tuesday.Following the market opening Tuesday, the Dow traded down 0.20% to 38,493.85 while the NASDAQ fell 0.22
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of Healthequity Inc (NASDAQ:HQY) rose sharply in today's pre-market trading as the company reported better-than-expected first-quarter financial results.The company reported quarterly earnings
Express News | Avalon GloboCare Shares Resume Trade
Express News | Avalon GloboCare Shares Halted On Circuit Breaker, Stock Now Up 283.1%
Trending Stocks Today: Avalon GloboCare Surges 171.49%
June 3rd - US stocks trending in regular trading hours.Gainers: $Avalon GloboCare(ALBT.US)$ surges 171.49% to $0.8 with a turnover of $79.43 million. $Microbot Medical(MBOT.US)$ soars 50.5% to $1.51 w
Express News | Avalon GloboCare Shares Resume Trading Following Circuit Breaker Halt
Avalon GloboCare | 10-Q: Quarterly report
Avalon GloboCare Receives Notice From Nasdaq Regarding Delayed Quarterly Report
FREEHOLD, N.J., May 24, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today
La Rosa Appoints Corporate Finance Executive Lourdes Felix to Its Board of Directors
Celebration, FL, May 21, 2024 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) ("La Rosa" or the "Company"), a holding company for five agent-centric, technology-integrated, cloud-based, multi-service real
Express News | Avalon Globocare - Got Letter From Nasdaq Advising Co Granted 180-Day Extension to Oct 28, to Regain Compliance With Min Bid Price Requirement
Express News | Avalon GloboCare Announces Launch Of U.S. Sales Of KetoAir Breathalyzer At Hack Your Health By KetoCon 2024 Conference
Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference
FREEHOLD, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today
Express News | Avalon GloboCare Shares Are Trading Higher After the Company Announced the Extension of Its Exclusive Distribution Agreement With Qi Diagnostics to Distribute the KetoAir Breathalyzer Device and Related Accessories in North America, South America, the Uni
Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union
Avalon GloboCare Extends Exclusive Distribution Agreement for KetoAir Breathalyzer | NASDAQ:ALBT
Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US
FREEHOLD, N.J., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today
Avalon GloboCare Partners With Qi Diagnostics To Co-Develop International Multi-Center Clinical Studies For DKAir Breathalyzer Device For The Early Detection Of Diabetic Ketoacidosis
Avalon GloboCare Partners With Qi Diagnostics To Co-Develop International Multi-Center Clinical Studies For DKAir Breathalyzer Device For The Early Detection Of Diabetic Ketoacidosis
It's Probably Less Likely That Avalon GloboCare Corp.'s (NASDAQ:ALBT) CEO Will See A Huge Pay Rise This Year
Key Insights Avalon GloboCare will host its Annual General Meeting on 12th of October Total pay for CEO David Jin includes US$360.0k salary The total compensation is similar to the average for the
Analysis
Price Target
No Data
